Introducing a new era of biomedical discovery.​ ​ The Jackson Laboratory has acquired The New York Stem Cell Foundation Research Institute. This powerful new alliance brings together complementary strengths across mouse, cell, and computational systems — creating an unmatched platform to accelerate the pace of discovery and turn possibility into progress for patients around the world. | The Jackson Laboratory

🌍 300 million people worldwide live with a rare disease. 👶 Up to 75% are children. 💊 Only 5% of rare diseases have an FDA-approved therapy. The JAX Rare Disease Translational Center is committed to changing these outcomes. Led by Vice President Cat Lutz, the team of 60 scientists and staff are advancing rare disease research—bringing targeted therapies from the lab to the clinic faster. ➡️ Learn more about the RDTC below and here: https://www.jax.org/research-and-faculty/research-centers/rare